Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,365,188
-
Share change
-
+2,704,282
-
Total reported value
-
$59,565,613
-
Put/Call ratio
-
63%
-
Price per share
-
$2.10
-
Number of holders
-
62
-
Value change
-
+$5,696,862
-
Number of buys
-
29
-
Number of sells
-
21
Institutional Holders of INFINITY PHARMACEUTICALS INC - COM (INFI) as of Q1 2018
As of 31 Mar 2018,
INFINITY PHARMACEUTICALS INC - COM (INFI) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,365,188 shares.
The largest 10 holders included
BVF INC/IL, FMR LLC, VANGUARD GROUP INC, Ghost Tree Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, PLATINUM INVESTMENT MANAGEMENT LTD, BlackRock Inc., Marshall Wace North America L.P., DIMENSIONAL FUND ADVISORS LP, and BAKER BROS. ADVISORS LP.
This page lists
62
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.